Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News AHA 2015 At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation L.A. McKeown November 08, 2015
News Conference News AHA 2013 Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR Yael L. Maxwell November 19, 2013